Sparingvision
$177.1Mtotal raised · 4 rounds on record
$48.1Mlatest round · Venture round · Oct 2026 · this month
3backers · AdBio, Jeito Capital
$2.7Mgrants · 1 grant · CORDIS
Funding and backers
Total raised
$177.1M
4 rounds on record
Latest round
$48.1M
Venture round · Oct 2026 · this month
Team
11-50
employees, estimated range
Grants
$2.7M
1 grant · CORDIS
Backers
3
AdBio, Jeito Capital
The money's age
Fresh money
0 months since the last round · not hiring
Momentum
35/100
in the news, fresh money
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Oct 16
Raised a round Venture round $48.1M · pharmaphorum
Apr 5, 2023
Board appointment SparingVision appoints Joseph C. Papa as Chairman · uk.finance.yahoo.com
Sep 14, 2022
Raised a round Series B $81M · FinanzNachrichten.de
Oct 20, 2020
Raised a round Venture round $48.1M · pharmaphorum
Aug 1, 2019
Won a grant $2.7M · CORDIS
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Oct 2026 | $48.1M | — | pharmaphorum |
| Series B | Sep 2022 | $81M | — | FinanzNachrichten.de |
| Venture round | Oct 2020 | $48.1M | — | pharmaphorum |
| Grant | Aug 2019 | $2.7M | — | CORDIS |
Backed byfrom the funds' portfolios and accelerator catalogs
AdBio 
Jeito Capital 
Ysios Capital Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
SparingVision raises €44.5m for retinitis pigmentosa gene therapy
French biotech SparingVision has raised 44.5 million euros to further develop its gene therapy for a rare ocular disease.
Read more
Report
Employee Spotlight: Jérôme Maës, Director, Global Project Lead
In today's blog, it is our pleasure to introduce you to Jérôme Maës, Director, Global Project Lead. Hi Jérôme, Can you tell us what is your role at SparingVision? As Head of Program Management, my role at SparingVision is to ensure the progress and coordi
Read more
Report
Employee Spotlight: Baptiste Erout, Scientist, Laboratory Operations
In today's blog, it is our pleasure to introduce you to Baptiste Erout, Scientist, Laboratory Operations. Hi Baptiste, Can you tell us what is your role at SparingVision? I am a Scientist responsible for laboratory operations within the Chemistry, Manufac
Read more
Report
SparingVision Successfully Completes PRODYGY Trial Patient Dosing with SPVN06, its Novel Neuroprotective Gene Therapy
All patients dosed with SPVN06 in Phase I/II trial continue to demonstrate a favorable safety profileInitial data readout for this novel gene-agnostic therapy expected in 2027Paris, February 9, 2026 - SparingVision (
Read more
Report
SparingVision Successfully Completes PRODYGY Trial Patient Dosing with SPVN06, its Novel Neuroprotective Gene Therapy
SparingVision Successfully Completes PRODYGY Trial Patient Dosing with SPVN06, its Novel Neuroprotective Gene Therapy All patients dosed with SPVN06 in Phase I/II trial continue to demonstrate a favorable safety profile Initial data readout for this novel
Read more
Report
SparingVision Successfully Completes PRODYGY Trial Patient Dosing with SPVN06, its Novel Neuroprotective Gene Therapy
All patients dosed with SPVN06 in Phase I/II trial continue to demonstrate a favorable safety profileInitial data readout for this novel gene-agnostic therapy expected in 2027 Paris, February 9, 2026 - SparingVision (
Read more
Report
Employee Spotlight: Pierre-Axel Vinot, Senior Director, CMC
In today's blog, it is our pleasure to introduce you to Pierre-Axel Vinot, Senior Director, CMC. Hi Pierre-Axel, Can you tell us what is your role at SparingVision? My role as Chemistry, Manufacturing, and Control (CMC) Director, involves leading the effo
Read more
Report
Employee Spotlight: Pauline Jacquety, Regulatory Affairs Senior Manager
In today's blog, it is our pleasure to introduce you to Pauline Jacquety, Regulatory Affairs Senior Manager. Hi Pauline, Can you tell us what is your role at SparingVision? I am a Regulatory Affairs Senior Manager. My role focuses on coordinating the prep
Read more
Report
Employee Spotlight: Alice Le Meur, Head of Clinical Operations
In today's blog, it is our pleasure to introduce you to Alice Le Meur, Head of Clinical Operations. Hi Alice, Can you tell us what is your role at SparingVision? I am the Head of Clinical Operations, leading a team of four Clinical Project Managers who ov
Read more
Report
SparingVision Conference Participation in H1 2026
SparingVision Conference Participation in H1 2026 Paris, 11 December 2025 - SparingVision ("the Company"), a clinical-stage genomic medicine company transforming the treatment of retinal disease, today announces the conferences its management team will pa
Read more
Report
Show more news